Individual risk prediction of high grade prostate cancer based on the combination between total prostate-specific antigen (PSA) and free to total PSA ratio.
Ferraro S, Biganzoli D, Rossi RS, Palmisano F, Bussetti M, Verzotti E, Gregori A, Bianchi F, Maggioni M, Ceriotti F, Cereda C, Zuccotti G, Kavsak P, Plebani M, Marano G, Biganzoli EM.
Ferraro S, et al. Among authors: rossi rs.
Clin Chem Lab Med. 2023 Jan 27;61(7):1327-1334. doi: 10.1515/cclm-2023-0008. Print 2023 Jun 27.
Clin Chem Lab Med. 2023.
PMID: 36704961
Free article.